Hang in there guys.
The business is debt free. Organic growth in the industry is flat and SMSF practices have been under intense pressure fee wise. Nevertheless, the business is being steered on the right track with the objective of a growing sustainable profit.
The dead wood businesses have been jettisoned and there is a list a mile long of older practitioners looking to leave the industry which will accelerate if there are significant legislative changes.
A major overhang over the stock is the involvement of CBA on the share register and the 2nd guessing as to what they may do in light of the Royal commission fallout.
I would hope the H1 FY2019 result will show a NPAT north of $2m, evidencing traction in the turnaround program. That would support a 1.5c dividend which may attract the yield based holders who abandoned the stock when the dividend was suspended.
